Ajinomoto Health & Nutrition North America, Inc.

Ajinomoto Health & Nutrition North America, Inc.

Starting Over: Reprogramming Cells in Regenerative Medicine

Reading Time: 2 minutes

Dr. Shinya Yamanaka began his career as an orthopedic surgeon but realized that even talented surgeons could not cure intractable diseases. Experience seeing patients with such diseases as rheumatism and bone cancer had made him decide to start over – as a research scientist.

Humans begin life as a fertilized egg called a zygote. The cell divides and multiplies until there are more than a trillion of them in the body. As cells grow, they become more specialized, eventually forming the various cell types of the body such as the heart, brain, bone, muscle, and skin cells.

In the early stage, cells have the potential to become any type of cell in the human body, a characteristic that is called “pluripotent.” For decades, scientists have dreamed of using pluripotent cells, a kind of stem cell, to advance human health. Stem cells might even allow doctors to regenerate parts of failing organs.

According to earlier studies, genes were switched on and off by the winding strands of DNA (deoxyribonucleic acid). Dr. Yamanaka realized that it might be possible to reverse mature cells to their pluripotent state by stimulating them with certain factors. It took his team several years of dedicated research to prove his theories and develop induced pluripotent stem cells, or iPS cells.

In 2012, Dr. Shinya Yamanaka and Sir John B. Gurdon were awarded the Nobel Prize in Physiology or Medicine for the discovery that mature cells can be reprogrammed to a pluripotent state.

iPS cells have immense potential for medical applications because the cells can grow indefinitely and can be differentiated into several types of cells in the human body.

Given Ajinomoto Group’s ability in amino acid research and production, partnering with Dr. Yamanaka’s Center for iPS Cell Research and Application (CiRA) at Kyoto University was a natural fit. In 2014, we announced the joint development of StemFit®, a high-performance, high-quality culture medium that allows cells to proliferate at rapid growth rates, minimizing the risk of biological contamination and enhancing safety.

Regenerative medicine using iPS cells have reached clinical studies/trials for a few diseases. We stay optimistic about its potential to save lives and enhance the quality of life of millions of patients around the world.

It is never too late to start over.

Regenerative Medicine
Health & Well-beingInnovation

You may also like

In recent years, the popularity of plant-based meat skyrocketed due to consumer intrigue in an animal alternative that was more sustainable, ethical, and nutritious. However, the velocity at which these products are selling has waned, with the narrative in the food industry shifting toward skepticism and criticism.
We are thrilled to share that as of January 3, 2023 Ajinomoto Health and Nutrition North America, Inc. (AHN) has acquired the remaining shares of More Than Gourmet (MTG), completing the acquisition.
#IFTFIRST has come and gone, but we’re still thinking about it! We loved getting to interact with other industry professionals, showcase our solutions and ingredients through delicious lunches each day, participate on panels and so much more! Eva Ryan, one of our summer interns, wrapped up our experience at #IFTFIRST in our latest story on ajihealthandnutrition.com! Check